Hear What Colin Hill had to say to Sidley on AI Use in Drug Discovery
Stephen Abreu, Sidley partner, talks to our Colin Hill about how the use of AI is revolutionizing the biotech space. Colin explains how our ability to predict and understand the actions of biological systems has historically been limited because of the complexity of “genetic circuitry,” but AI has allowed us to develop a more quantitative […]
CTAD Poster | Prediction of Amyloid PET positivity from blood-based biomarkers and clinical data using AI-based Digital Twins
Wenjun Zhu, So-Youn Shin, Jeanne Latourelle
Webinar | From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease
Alzheimer’s disease research has taken center stage in the world of drug discovery and clinical development. The convergence of causal AI, supercomputing power, and multi-omic human data is allowing us to begin to unravel the molecular circuity of this debilitating disease in order to discover the next generation of breakthrough drugs and predictive biomarkers. In […]
MDS Poster | Gemini Digital Twins Identified Neuro-Common and Disease-Specific Drivers of Blood NfL Change Rate
X.Shen, S.Sathe, L.Sun, P.Ashrap, K.Johnson, S.Sukhram, S.Reddy, S-Y.Shin, J.Latourelle, C.Sampaio
Exploring the Frontiers of AI-driven Drug Discovery: A Conversation with Aitia on The Long Run Podcast
Colin Hill joined Luke Timmerman on “The Long Run” podcast, to explore Aitia’s journey and its impact on the realm of drug discovery. In this episode, Colin and Luke delve into the genesis of Aitia. From its humble beginnings to its current status as a pioneering in the industry. 🎧 If you would like to […]
Servier and Aitia Mobilize AI and Digital Twins to Treat Pancreatic Cancer
The French pharmaceutical group Servier and Aitia announced on May 17th a multi-year partnership agreement for the discovery and simulation of drugs in pancreatic cancer. It is based on the combination of Servier’s expertise in preclinical trials with Aitia’s technology, which is based on artificial intelligence and Gemini Digital Twins. Read more on the latest […]
AAIC Poster | Alzheimer’s Disease Mechanistic Pathways were Discovered through in silico Experiments in Causal AI based Digital Twins
Apoorva Bharthur Sanjay, Deepanshi Shokeen, Xinyu Shen, So-Youn Shin and Jeanne Latourelle
Colin Hill Weighs in on the Future of Drug Discovery on the Patients Rising Podcast
Our CEO, Colin Hill was a special guest on the Patients Rising Podcast. In this week’s episode, Colin passionately shared his beliefs and vision for the future of medical research, highlighting the transformative potential of AI-powered clinical trials and the revolutionary power of Digital Twins. Tune in to the podcast episode now and discover how Digital […]
Open to Debate: Is the FDA’s Caution Hazardous to your Health?
During the COVID-19 pandemic, the Atlantic lambasted the US Food and Drug Administration for moving too slowly to approve vaccines with the provocative headline “The Death Toll of Delay.” Not long before, National Public Radio had run a piece titled “One-Third of New Drugs Had Safety Problems After FDA Approval.” As the agency tries to […]
HD Therapeutics Conference Poster | Gemini Digital Twins Identified Both Common and Disease-specific Drivers of Cognitive Progression in Huntington’s and Alzheimer’s Diseases
L.Sun, S.Sathe, X.Shen, P.Ashrap, K.Johnson, S.Sukhram, S.Reddy, S-Y.Shin, J.Latourelle, C.Sampaio